Volume 17, Issue 3 ( Aug_Sep 2013)                   2013, 17(3): 48-57 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Honardoost M, Soleimanjahi H, Rajaei F. Apoptosis: programmed cell death . Journal of Inflammatory Diseases. 2013; 17 (3) :48-57
URL: http://journal.qums.ac.ir/article-1-1492-en.html
1- Cellular & Molecular Research Centre, Qazvin University of Medical Sciences
2- Tarbiat Modarres University
3- , farzadraj@yahoo.co.uk
Abstract:   (26983 Views)

  Apoptosis or programmed cell death is known as a conserved gene-directed mechanism for the specific elimination of unnecessary or unwanted cells from an organism and is involved in many immune system mechanisms and diseases . The main differences of this pathway with cell necrosis as two main pathways for elimination of unwanted cells are the absence of inflammation and the restricted effect on target cells. Apoptosis has an important role in biological processes such as normal development, tissue homeostasis, elimination of destroyed cells or virus infected cells and remove of self antigen-activated immune cells. A poptosis is important for regulation of cell growth and proliferation, development and body health and many autoimmune diseases, cancers and viral infections are the result of impaired or inhibited programmed cell death . Therefore the main objective of apoptosis research is to identify molecular components and regulatory mechanisms specially Bcl-2 and IAP family as the most important regulators of apoptosis and this information may lead to application of therapeutic agents that can modulate this process in the treatment of neurodegenerative disorders and proliferative diseases such as cancer.





Full-Text [PDF 325 kb]   (38324 Downloads)    
Type of Study: Review article | Subject: Anatomy

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb